This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan DNAJB1 paraffin-section IHC around nuclear and cytoplasmic tissue staining (HPA tissue IHC). This guide covers high-staining tissue references (HPA tissue IHC), the catalog antibody’s 2–5 μg/mL IHC range (datasheet A03100-1), and heat-shock redistribution (UniProt).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Nucleus and cytoplasm (HPA tissue IHC) | |
| Staining pattern | General nuclear and cytoplasmic staining in tissue cells (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A03100-1) | |
| Positive control | Adrenal gland+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
| Fixation | Keep paraffin-section fixation consistent (standard IHC practice; not target-specific); Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A03100-1) | |
| Caveat | Heat shock can shift signal toward nucleoli (UniProt) | |
| Regulation | Abundance changes are unreported (UniProt) | |
| Isoform / epitope | 2 isoforms; epitope coverage is unspecified (UniProt) |
The catalog antibody protocol uses EDTA pH 8.0 heat retrieval (datasheet A03100-1). The published protocols below describe fish ovary frozen sections (PMC6485077) and liver sections (PMC11278829).
| Sample | Paraffin-embedded human gastric signet ring cell carcinoma tissue; fixative not specified (datasheet A03100-1) |
| Fixation | Image fixative and duration unreported (datasheet A03100-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A03100-1); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A03100-1) |
| Primary antibody | Rabbit anti-DNAJB1, 2-5 μg/ml (datasheet A03100-1) |
| Primary incubation | Overnight at 4 °C (datasheet A03100-1) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet A03100-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DNAJB1-positive staining in glandular cells of adrenal gland (HPA tissue IHC: High). HPA tissue profile: General nuclear and cytoplasmic expression. No signal in the no-primary control. |
DNAJB1 staining is expected in nuclei and cytoplasm in paraffin sections (HPA: general nuclear and cytoplasmic expression). High staining is reported in skin basal cells, bronchial respiratory epithelium and adrenal glandular cells (HPA: High in each). The tissue pattern has Enhanced reliability, reflecting agreement between staining and RNA data (HPA: Enhanced). DNAJB1 has no transmembrane segment (UniProt P25685 topology).
| Nuclear and cytoplasmic staining in the expected cells. | This fits the reported tissue pattern (HPA: general nuclear and cytoplasmic expression). Judge intensity within the identified cell population; adjacent cells need not stain equally. |
| Strong membrane, extracellular or lumenal staining dominates. | Treat this as suspect staining: DNAJB1 lacks a transmembrane segment and signal peptide (UniProt P25685 topology and processing). Review the no-primary control and tissue morphology before assigning a cellular signal (general IHC practice). |
| Strong staining occurs mainly in cells outside the reported population. | Check for cross-reactivity or endogenous detection activity (general IHC practice). For example, skin basal cells are reported High (HPA: High in skin basal layer); staining elsewhere alone needs corroboration. |
| Diffuse color covers tissue and empty spaces. | This is consistent with assay background rather than a resolved nuclear and cytoplasmic pattern (general IHC practice; HPA: tissue IHC profile). Compare with a no-primary control and inspect whether cell boundaries remain interpretable. |
| No staining appears in a known-positive tissue. | First investigate assay failure or specimen variation; a negative slide does not establish DNAJB1 absence (general IHC practice). Bronchial respiratory epithelial cells are a reported High reference (HPA: High in bronchus). |
| Cell population and comparator tissue | HPA reports High staining in several epithelial and glandular populations, but Low in heart muscle cardiomyocytes and small-intestine glandular cells (HPA: tissue IHC). Low is a weaker comparator, not a verified negative control. |
| Compartment and stress state | Routine tissue IHC is described as nuclear and cytoplasmic (HPA: tissue IHC). DNAJB1 can move toward nuclei, especially nucleoli, after heat shock (UniProt P25685 subcellular annotation); nucleolar enrichment alone does not establish that stress occurred. |
| Antibody validation | HPA063247 has Enhanced IHC validation; CAB017450 has Supported IHC validation (HPA: antibody records). These statuses support interpretation of their observed patterns, but do not validate every specimen or detection setup (general IHC practice). |
| Isoforms and epitope coverage | DNAJB1 has 2 recorded isoforms (UniProt P25685 isoforms). The supplied evidence does not map the catalog antibody's epitope or isoform coverage, so a weak result cannot be assigned to an isoform without further validation. |
| Detection background | Endogenous enzyme activity or nonspecific secondary binding can add chromogenic color (general IHC practice). A no-primary control helps separate detection background from the reported cellular pattern (HPA: tissue IHC profile; general IHC practice). |
| Situation | Likely cause | Next action |
|---|---|---|
| High-reference tissue has little or no signal. | A detection or staining step may have failed; tissue handling may also differ (general IHC practice). | Confirm the expected cell population, then review antibody dilution, retrieval and detection against the catalog antibody's IHC-P protocol; no target-specific fixation sensitivity is supplied (HPA: High tissue IHC; general IHC practice). |
| Membrane or extracellular color overwhelms cellular staining. | The dominant compartment conflicts with the reported pattern (HPA: tissue IHC; UniProt P25685 topology). | Inspect morphology and a no-primary control, then reassess blocking and detection conditions (general IHC practice). Avoid scoring this color as DNAJB1 without independent support. |
| Color appears broadly across cells reported Low. | Background or cross-reactivity is possible, although Low does not mean absent (HPA: Low tissue IHC; general IHC practice). | Compare the no-primary control and a reported High cell population in the same run; score the cell type and compartment separately from overall slide color (HPA: tissue IHC; general IHC practice). |
| Tissue edges and empty spaces show diffuse color. | Poorly resolved chromogen or nonspecific detection may obscure the cellular pattern (general IHC practice). | Check a no-primary control, blocking and wash steps; interpret only staining that can be assigned to intact nuclei or cytoplasm (general IHC practice; HPA: tissue IHC profile). |
| A second antibody gives a different pattern. | HPA reports different IHC validation levels for HPA063247 and CAB017450 (HPA: antibody records); discordance alone does not identify which result is correct. | Compare the same tissue and cell population, include detection controls, and favor a reproducible pattern matching HPA tissue IHC and UniProt localisation (general IHC practice; HPA: tissue IHC; UniProt P25685 subcellular annotation). |
| What should an IF/ICC image show? | HPA reports mainly nucleoplasmic DNAJB1 with additional cytosolic localisation in ICC-IF (HPA: supported subcellular locations). | Use those compartments as an image interpretation reference; consult the separate IF/ICC guide for its workflow (HPA: ICC-IF subcellular profile). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | Glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | Respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cervix | Squamous epithelial cells | High | Protein (IHC) | HPA → |
| Esophagus | Squamous epithelial cells | High | Protein (IHC) | HPA → |
| Gallbladder | Glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: DNAJB1 is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Troubleshoot DNAJB1 staining in paraffin sections by checking retrieval, compartment patterns, controls, and cell specific scoring before interpreting signal.
A03100-1 has IHC data from human paraffin sections (IHC caption) and IF/ICC data from A549 cells (IF caption); catalog reactivity lists human, mouse and rat (catalog: reactivity).
A03100-1 will render with IHC data from a paraffin section of human gastric signet ring cell carcinoma tissue (IHC caption). A03100-1 is also listed for IF/ICC, with an image of A549 cells (catalog: applications; IF caption).
Which to pick: Choose A03100-1 for paraffin-section IHC: its image caption documents EDTA retrieval at pH 8.0 and 2 μg/ml primary antibody; the fixative is unreported (IHC caption). For IF/ICC, the same SKU has an A549 cell image using 5 μg/ml primary antibody (IF caption). For mouse or rat work, A03100-1 lists those species as reactive, but the supplied IHC and IF images show human samples; no clone is specified (catalog: reactivity and clone; IHC/IF captions).